Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Martin Boorsma"'
Autor:
Martin Boorsma, Karen I. Maassen Van Den Brink, Emiel F.M. Wouters, A. Jeske Staal-van den Brekel, Lars Thorsson, Staffam Edsbäcker
Publikováno v:
British Journal of Clinical Pharmacology, 66(1), 27-35. Wiley
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • In vitro studies with human bronchial epithelial cells have shown that budesonide undergoes rapid, extensive and reversible intracellular esterification, a finding that is believed to contribute to retenti
Autor:
René Lutter, Martin Boorsma, Marianne A. van de Pol, Theo A. Out, René E. Jonkers, Henk M. Jansen
Publikováno v:
COPD, 4(4), 321-329. Informa Healthcare
RATIONALE: Limited information is available on repeatability of inflammatory parameters in whole induced sputum samples from patients with COPD. OBJECTIVES: To study short-term and long-term repeatability in induced sputum samples in 22 patients with
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 17:89-95
Inhalers containing corticosteroids and long-acting beta2-agonists are becoming increasingly important in asthma management. A rapid effect is important to patients, particularly during exacerbations. We compared the onset of bronchodilation and pati
Publikováno v:
Respiratory Research, Vol 11, Iss 1, p 66 (2010)
Respiratory Research, 11. BioMed Central
Respiratory research, 11. BioMed Central
Respiratory Research
Respiratory Research, 11. BioMed Central
Respiratory research, 11. BioMed Central
Respiratory Research
Background The budesonide/formoterol combination is successfully used for fast relief of asthma symptoms in addition to its use as maintenance therapy. The temporarily increased corticosteroid dose during increasing inhaler use for symptom relief is
Autor:
Dirkje S. Postma, Erik Bathoorn, Huib A. M. Kerstjens, Eva Bondesson, Henk F. Kauffman, Martin Boorsma, Jeroen J W Liesker, Gerard H. Koëter, Antoon J. M. van Oosterhout
Publikováno v:
COPD: Journal of Chronic Obstructive Pulmonary Disease, 5(5), 282-290. Taylor & Francis Group
Systemic corticosteroids and additional short-acting beta 2-agonists are commonly used in exacerbations of chronic obstructive pulmonary disease (COPD). In this double-blind study, the combination of a high-dose inhaled corticosteroid with a rapid-on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e1aa1f868b8db18dfad7c0a78bed388
https://research.rug.nl/en/publications/8af323b2-9e5d-462f-b086-fa5cd8cf9334
https://research.rug.nl/en/publications/8af323b2-9e5d-462f-b086-fa5cd8cf9334